McKesson Corporation (MCK) fell 1.26% on October 1, 2026, closing at $854.42 as selling pressure continued to weigh on the pharmaceutical distribution giant. The one-day decline added to a broader pattern of weakness in the stock.
Over the past seven days, MCK has dropped 3.03%, and the 30-day picture shows a loss of 3.45%, suggesting sustained downward momentum across near- and medium-term timeframes.
Despite the recent price erosion, McKesson retains a market capitalization of $100.83 billion, reflecting its standing as one of the larger companies in the healthcare sector by that measure.
The stock's consecutive losses across the one-day, seven-day, and thirty-day windows mark a consistent retreat from recent levels, with no single timeframe showing a recovery in the current period examined.
